Brief: Valneva Announces Lifting Of EMA's Temporary Restriction On Use Of Chikungunya Vaccine IXCHIQ® In Elderly
11/07/2025 16:50
July 11 (Reuters) - Valneva SE VLS.PA: ANNOUNCES LIFTING OF EUROPEAN MEDICINES AGENCY'S TEMPORARY RESTRICTION ON USE OF CHIKUNGUNYA VACCINE IXCHIQ® IN ELDERLY EMA TO LIFT RESTRICTION ON VACCINATING PEOPLE 65+ Source text: ID:nGNE79LFjD Further company coverage: VLS.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency